InsiderTrades

Form 4 for CELU Celularity Inc

Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-01 · accession 0001567619-22-006998 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2022-03-15 2022-03-01 CELU STARR INTERNATIONAL CO INC 10% X - OptEx $3.50 +6.64M 15.28M +77% +$23.24M
DI 2022-03-15 2022-03-01 CELU STARR INTERNATIONAL CO INC 10% X - OptEx $0.00 -6.64M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-03-01 X A 6,640,694 $3.50 15,281,389 I See footnote — — (F1) The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.
2 Derivative Warrant (Right to Buy) 2022-03-01 X D 6,640,694 $0.00 0 I See footnote $3.50 · 2021-07-16 to — 6,640,694 Class A Common Stock (F1) The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form. (F2) The first to occur of: (a) March 16, 2025 or (b) the consummation of a Change of Control (as defined in the applicable warrant agreement) following March 1, 2022.